On Thursday, Exscientia plc (NASDAQ:EXAI) agreed to merge with Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). Exscientia shareholders will receive 0.7729 Recursion shares for each Exscientia share, ...
The combined entity will have $850 million in cash and about $200 million in expected milestones over the next 24 months. The combined company is estimated to achieve approximately $100 million in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback